TheraRadar
← Back
Data updated: Jul 17, 2026

FLEMING PHARMS

Generics
Pharmaceuticals

FLEMING PHARMS is a generic drug manufacturer with 4 FDA-approved products.

1986
Since
4
Drugs
-
Trials
0
New Drugs (2yr)

FLEMING PHARMS's Key Drugs

FLEMING PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

FLEMING PHARMS's Recent FDA Approvals

New NDA/BLA approvals for FLEMING PHARMS over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

FLEMING PHARMS's Therapeutic Areas

Disease areas where FLEMING PHARMS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

FLEMING PHARMS Pipeline Snapshot

Active clinical trials for FLEMING PHARMS across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling